Biotechnology

Cancer-fighting version of herpes shows promise in early human trials

Cancer-fighting version of herpes shows promise in early human trials

Illustration of herpes simplex virus. illustration: Shutterstock (Shutterstock) Scientists may be able to turn a long-standing bacterial foe into a cancer-fighting ally, a new study this week suggests. In preliminary data from a phase I trial, a genetically modified version of the herpes virus has shown promise in treating hard-to-eradicate tumors, with one patient in …

Cancer-fighting version of herpes shows promise in early human trials Read More »

CDC panel recommends new omicron Covid booster, injections expected to start next week

CDC panel recommends new omicron Covid booster, injections expected to start next week

Justin Sullivan | Getty Images The Centers for Disease Control and Prevention’s Independent Committee on Vaccines recommends reformulation of booster shots for the latest omicron sub-variants. After reviewing available safety and efficacy data in a nearly seven-hour meeting, the group voted 13-1 on Thursday to support the shots. CDC Director Dr. Rochelle Walensky still needs …

CDC panel recommends new omicron Covid booster, injections expected to start next week Read More »

Study finds little to no benefit of Pfizer's antiviral drug in young adults, WHO says BA.5 omicron subvariant accounts for 74% of cases in recent week

Study finds little to no benefit of Pfizer’s antiviral drug in young adults, WHO says BA.5 omicron subvariant accounts for 74% of cases in recent week

Pfizer’s COVID antiviral drug Paxlovid appears to have little benefit in young people, although it still reduces the risk of hospitalization or death in older adults, according to a new study in Israel. Data from the 109,000-patient study could reignite questions about the U.S. government’s use of Paxlovid, which has become the treatment of choice …

Study finds little to no benefit of Pfizer’s antiviral drug in young adults, WHO says BA.5 omicron subvariant accounts for 74% of cases in recent week Read More »

A dog in France has monkeypox, and scientists fear we won't be able to eradicate the virus if it spreads to more animals

A dog in France has monkeypox, and scientists fear we won’t be able to eradicate the virus if it spreads to more animals

Monkeypox virus, illustration. Tom Ritchie | Science Photo Gallery | Getty Images In 2003, 47 people in six Midwestern states were infected with monkeypox from pet marmots that were raised by rodents imported from Ghana, Africa. Today’s outbreak, which has infected more than 14,100 people in the United States and more than 41,000 globally, has …

A dog in France has monkeypox, and scientists fear we won’t be able to eradicate the virus if it spreads to more animals Read More »